Cited by

• Demographics and clinical and economic characteristics of patients receiving total hip arthroplasty with and without muscle atrophy/weakness.

  Wu N, Chen SY, Lee YC, Zhao Y. Wu N, et al. Clinicoecon Outcomes Res. 2013 Jun 25;5:271-80. doi: 10.2147/CEOR.S46332. Print 2013. Clinicoecon Outcomes Res. 2013. PMID: 23836997 Free PMC article.
• High Rates of Aseptic Loosening After Revision Total Knee Arthroplasty for Periprosthetic Joint Infection.

  Kienzle A, Walter S, von Roth P, Fuchs M, Winkler T, Müller M. Kienzle A, et al. JB JS Open Access. 2020 Aug 12;5(3):e20.00026. doi: 10.2106/JBJS.OA.20.00026. eCollection 2020 Jul-Sep. JB JS Open Access. 2020. PMID: 32984749 Free PMC article.
• Haemodynamics, side effects and safety of the combination of continuous femoral nerve block and intravenous parecoxib for pain management after Total Knee Arthroplasty: A pilot study.

  Sarridou D, Gkiouliava A, Argiriadou H, Amaniti A, Chalmouki G, Vadalouka A. Sarridou D, et al. Orthop Rev (Pavia). 2024 Sep 14;16:122536. doi: 10.52965/001c.122536. eCollection 2024. Orthop Rev (Pavia). 2024. PMID: 39286466 Free PMC article.
• Comparison between gaits after a medial pivot and posterior stabilized primary total knee arthroplasty: a systematic review of the literature.

  Risitano S, Cacciola G, Capella M, Bosco F, Giustra F, Fusini F, Indelli PF, Massé A, Sabatini L. Risitano S, et al. Arthroplasty. 2023 Mar 17;5(1):15. doi: 10.1186/s42836-023-00165-8. Arthroplasty. 2023. PMID: 36927464 Free PMC article. Review.
• Vancomycin-Loaded, Nanohydroxyapatite-Based Scaffold for Osteomyelitis Treatment: In Vivo Rabbit Toxicological Tests and In Vivo Efficacy Tests in a Sheep Model.

  Alegrete N, Sousa SR, Padrão T, Carvalho Â, Lucas R, Canadas RF, Lavrador C, Alexandre N, Gärtner F, Monteiro FJ, Gutierres M. Alegrete N, et al. Bioengineering (Basel). 2023 Feb 4;10(2):206. doi: 10.3390/bioengineering10020206. Bioengineering (Basel). 2023. PMID: 36829700 Free PMC article.